Skye Bioscience, Inc. Operating Lease Cost
Skye Bioscience, Inc. (SKYE) reported Operating Lease Cost of $207.40 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-03-10
- Skye Bioscience, Inc. operating lease, cost for the quarter ending 2023-12-31 was $26.08K, a 15.00% increase year-over-year.
- Skye Bioscience, Inc. operating lease, cost for the quarter ending 2023-09-30 was $26.08K, a 15.00% increase year-over-year.
- Skye Bioscience, Inc. operating lease, cost for the quarter ending 2023-06-30 was $22.68K, a 0.00% change year-over-year.
- Skye Bioscience, Inc. operating lease, cost for the quarter ending 2023-03-31 was $23.16K, a 2.13% increase year-over-year.
- Skye Bioscience, Inc. operating lease, cost for fiscal 2025 was $207.40K, a 58.74% increase from fiscal 2024.
- Skye Bioscience, Inc. operating lease, cost for fiscal 2024 was $130.66K, a 33.34% increase from fiscal 2023.
- Skye Bioscience, Inc. operating lease, cost for fiscal 2023 was $97.99K, a 8.03% increase from fiscal 2022.
- Skye Bioscience, Inc. operating lease, cost for fiscal 2022 was $90.70K, a 200.00% increase from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $207.40K 10-K · filed 2026-03-10 | |||
| 2024-12-31 | $130.66K 10-K · filed 2026-03-10 | |||
| 2023-12-31 | $26.08K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $52.15K derived: sum of 2 quarters · filed 2025-03-20 | $74.83K derived: sum of 3 quarters · filed 2025-03-20 | $97.99K 10-K · filed 2025-03-20 |
| 2023-09-30 | $26.08K 10-Q · filed 2023-11-14 | $48.75K derived: sum of 2 quarters · filed 2023-11-14 | $71.91K 10-Q · filed 2023-11-14 | $94.58K derived: sum of 4 quarters · filed 2024-03-22 |
| 2023-06-30 | $22.68K 10-Q · filed 2023-08-07 | $45.83K 10-Q · filed 2023-08-07 | $68.51K derived: sum of 3 quarters · filed 2024-03-22 | $91.18K derived: sum of 4 quarters · filed 2024-03-22 |
| 2023-03-31 | $23.16K 10-Q · filed 2023-05-12 | $45.83K derived: sum of 2 quarters · filed 2024-03-22 | $68.51K derived: sum of 3 quarters · filed 2024-03-22 | $91.18K derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-12-31 | $22.68K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $45.35K derived: sum of 2 quarters · filed 2024-03-22 | $68.03K derived: sum of 3 quarters · filed 2024-03-22 | $90.70K 10-K · filed 2024-03-22 |
| 2022-09-30 | $22.68K 10-Q · filed 2023-11-14 | $45.35K derived: sum of 2 quarters · filed 2023-11-14 | $68.03K 10-Q · filed 2023-11-14 | $90.70K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $22.68K 10-Q · filed 2023-08-07 | $45.35K 10-Q · filed 2023-08-07 | $68.03K derived: sum of 3 quarters · filed 2023-08-07 | $75.58K derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $22.68K 10-Q · filed 2023-05-12 | $45.35K derived: sum of 2 quarters · filed 2023-05-12 | $52.91K derived: sum of 3 quarters · filed 2023-05-12 | |
| 2021-12-31 | $22.68K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $30.23K derived: sum of 2 quarters · filed 2023-03-31 | $30.23K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $7.56K 10-Q · filed 2022-11-14 | $7.56K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |